Biosergen (BIOSGN.ST) Stock Price
Biosergen Price
Revenue has compounded at 155.4% per year over the past 2 years to 8.57 M SEK. Biosergen's net margin stands at -403.1%, up from -412.5% several years earlier.
Biosergen stock price
Biosergen business model & stock analysis
Frequently asked questions about Biosergen
Converted at the current exchange rate, the Biosergen share trades at 0.04 EUR (0.48 SEK).
The expected revenue of Biosergen is 1.40 M SEK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Biosergen is -2.57 M SEK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Biosergen is currently -3.98. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Biosergen stock.
The price-to-sales ratio (P/S) of Biosergen is currently 7.32. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Biosergen stock.
The Eulerpool Quality Score for Biosergen is 2/10.
The ISIN of Biosergen is SE0026821852. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Biosergen is A3CSG0. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Biosergen is BIOSGN.ST. The ticker symbol is used to trade Biosergen shares on the stock exchange.
Biosergen stock
Biosergen Peer Group
All fundamentals and in-depth analysis of Biosergen
Our stock analysis for Biosergen stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biosergen. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.